Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Histology, Tumor Volume, and Radiation Dose Predict Outcomes in NSCLC Patients After Stereotactic Ablative Radiotherapy.
Shiue K, Cerra-Franco A, Shapiro R, Estabrook N, Mannina EM, Deig CR, Althouse S, Liu S, Wan J, Zang Y, Agrawal N, Ioannides P, Liu Y, Zhang C, DesRosiers C, Bartlett G, Ewing M, Langer MP, Watson G, Zellars R, Kong FM, Lautenschlaeger T. Shiue K, et al. J Thorac Oncol. 2018 Oct;13(10):1549-1559. doi: 10.1016/j.jtho.2018.06.007. Epub 2018 Jun 27. J Thorac Oncol. 2018. PMID: 29959060 Free PMC article.
Toxicity of Radiosurgery for Brainstem Metastases.
Patel A, Dong T, Ansari S, Cohen-Gadol A, Watson GA, Moraes FY, Nakamura M, Murovic J, Chang SD, Hatiboglu MA, Chung C, Miller JC, Lautenschlaeger T. Patel A, et al. Among authors: watson ga. World Neurosurg. 2018 Nov;119:e757-e764. doi: 10.1016/j.wneu.2018.07.263. Epub 2018 Aug 8. World Neurosurg. 2018. PMID: 30096494 Free article. Review.
Efficacy of pre-operative stereotactic radiosurgery followed by surgical resection and correlative radiobiological analysis for patients with 1-4 brain metastases: study protocol for a phase II trial.
Huff WX, Agrawal N, Shapiro S, Miller J, Kulwin C, Shah M, Savage JJ, Payner T, Vortmeyer A, Watson G, Dey M. Huff WX, et al. Radiat Oncol. 2018 Dec 20;13(1):252. doi: 10.1186/s13014-018-1178-8. Radiat Oncol. 2018. PMID: 30572923 Free PMC article. Clinical Trial.
Nearly Half of Metastatic Brain Disease Patients Prescribed 10 Fractions of Whole-Brain Radiation Therapy Die Without Completing Treatment.
McClelland S 3rd, Agrawal N, Shiue K, Bartlett GK, Zellars RC, Watson GA, Ellsworth SG. McClelland S 3rd, et al. Among authors: watson ga. J Pain Symptom Manage. 2019 Aug;58(2):e5-e6. doi: 10.1016/j.jpainsymman.2019.04.022. Epub 2019 Apr 25. J Pain Symptom Manage. 2019. PMID: 31029809 Free article. No abstract available.
Radiosurgery dose reduction for brain metastases on immunotherapy (RADREMI): A prospective phase I study protocol.
McClelland S 3rd, Lautenschlaeger T, Zang Y, Hanna NH, Shiue K, Kamer AP, Agrawal N, Ellsworth SG, Rhome RM, Watson GA. McClelland S 3rd, et al. Among authors: watson ga. Rep Pract Oncol Radiother. 2020 Jul-Aug;25(4):500-506. doi: 10.1016/j.rpor.2020.04.007. Epub 2020 Apr 23. Rep Pract Oncol Radiother. 2020. PMID: 32477016 Free PMC article. Review.
Isocitrate dehydrogenase 1 mutant glioblastomas demonstrate a decreased rate of pseudoprogression: a multi-institutional experience.
Mohammadi H, Shiue K, Grass GD, Verma V, Engellandt K, Daubner D, Schackert G, Gondim MJ, Gondim D, Vortmeyer AO, Kamer AP, Jin W, Robinson TJ, Watson G, Yu HM, Lautenschlaeger T. Mohammadi H, et al. Neurooncol Pract. 2020 Mar;7(2):185-195. doi: 10.1093/nop/npz050. Epub 2019 Oct 10. Neurooncol Pract. 2020. PMID: 32626587 Free PMC article.
104 results